Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734640 · ClinicalTrials.gov registry record · NA
Optimal Post Tpa-Iv Monitoring in Ischemic Stroke
A NA study of Acute Ischemic Stroke Patients Receiving Reperfusion Therapy, sponsored by Craig Anderson.
- Completed
- Registry status
- NA
- Development phase
- 4,922
- Enrollment target
- 20
- Study locations
NCT03734640 is a NA study of Acute Ischemic Stroke Patients Receiving Reperfusion Therapy that has completed, run by Craig Anderson. The registered enrollment target is 4,922 participants. The trial reports 20 study locations across 13 states.
The verdict
NCT03734640, a NA study of Acute Ischemic Stroke Patients Receiving Reperfusion Therapy, has completed, sponsored by Craig Anderson.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,922 participants
- Enrollment target
- 20
- Study locations
Study Summary
OPTIMISTmain is an investigator-initiated and conducted, international, multicentre, stepped wedge cluster randomized controlled trial comparing the effects of different intensities of nursing care monitoring for patients with acute ischemic stroke of mild severity and without critical care needs after IV-tPA.
Conditions Studied
Interventions
- OTHER Low-intensity monitoring strategy
- OTHER Guideline recommended standard monitoring
Study Locations (20)
Maryland
- University of Maryland Medical Center - Baltimore
- The John Hopkins Hospital - Baltimore
- Howard County General Hospital - Columbia
Missouri
- SSM Health DePaul Hospital - Bridgeton
- Saint Luke's Hospital of Kansas City - Kansas City
- Research Medical Center - Kansas City
Colorado
- Centura St. Anthony Hospital - Lakewood
- Centura Littleton Adventist Hospital - Littleton
Michigan
- Henry Ford Health System - Detroit
- Ascension Providence Hospital - Novi
Pennsylvania
- Lehigh Valley Health Network - Allentown
- Penn State Health - Hershey
Massachusetts
- University of Massachusetts Worcester - Worcester
Nevada
- Renown Health - Reno
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,922 participants |
| Start Date | 2021-04-28 |
| Est. Completion | 2025-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03734640
The ClinicalTrials.gov registry entry for NCT03734640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,922 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Craig Anderson, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Ischemic Stroke Patients Receiving Reperfusion Therapy appearing as the primary indexed condition, and to 2 interventions - of which Low-intensity monitoring strategy is the first listed.
NCT03734640 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Maryland, Missouri, Colorado.
Frequently Asked Questions
What is clinical trial NCT03734640 about?
NCT03734640 is a clinical study titled "Optimal Post Tpa-Iv Monitoring in Ischemic Stroke". OPTIMISTmain is an investigator-initiated and conducted, international, multicentre, stepped wedge cluster randomized controlled trial comparing the effects of different intensities of nursing care monitoring for patients with acute ischemic stroke of mild severity and without critical care needs af...
What is the current status of trial NCT03734640?
This trial is currently completed. It is a NA study. The enrollment target is 4,922 participants. The study started on 2021-04-28. Estimated completion is 2025-01-23.
What conditions does trial NCT03734640 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke Patients Receiving Reperfusion Therapy.
What interventions are being tested in trial NCT03734640?
The interventions under investigation include: Low-intensity monitoring strategy (OTHER), Guideline recommended standard monitoring (OTHER).
Who is sponsoring clinical trial NCT03734640?
This trial is sponsored by Craig Anderson, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03734640 being conducted?
This trial has 20 study locations across Colorado, Maryland, Massachusetts, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.